|
⚲
|
| Keyboard |
| Farzan Nima
✚
|
|
|---|---|
| CIK # | 0001808296 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808296] | |
| 4 | [0001808296] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Keros Therapeutics Inc | |
| Farzan Nima | |
| Kinnate Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2025-06-04 | Grant | 10,500 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2025-06-04 | Grant | 5,250 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2024-05-30 | Grant | 10,000 | $0.00 | |
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 437,413 | ||
|
Kinnate Biopharma Inc KNTE
Common Stock
|
2024-04-03 | Disposed to issuer | 2,186 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 1,281,642 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 750,000 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 275,000 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 400,000 | ||
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2023-06-06 | Grant | 10,000 | $0.00 | |
|
Kinnate Biopharma Inc KNTE
Employee Stock Option (right to buy) · derivative
|
2023-02-10 | Grant | 750,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Options (right to buy) · derivative
|
2022-06-01 | Grant | 8,293 | $0.00 | |
|
Kinnate Biopharma Inc KNTE
Employee Stock Option (right to buy) · derivative
|
2022-02-11 | Grant | 400,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2021-06-01 | Grant | 8,293 | $0.00 | |
|
Kinnate Biopharma Inc KNTE
Employee stock option (right to buy) · derivative
|
2021-02-12 | Grant | 275,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2020-05-29 | Grant | 8,500 | $0.00 |